Anixa Biosciences (ANIX) Gains from Investment Securities (2014)
Anixa Biosciences' (ANIX) quarterly Gains from Investment Securities came in at -$10.0 in Q4 2014, down 100.0% on a QoQ basis from $513122.0 in Q1 2014.
Anixa Biosciences (ANIX) Gains from Investment Securities (2014) Analysis & Trends
Anixa Biosciences (ANIX) has 1 years of Gains from Investment Securities data on file, last reported at -$10.0 in Q4 2014.
- Quarterly Gains from Investment Securities changed N/A year-over-year to -$10.0 in Q4 2014, while the trailing twelve-month figure through Oct 2014 was $513112.0 (changed N/A YoY) and the FY2014 annual result came in at $513112.0, up 138.86% from the prior year.
- Gains from Investment Securities fell to -$10.0 in Q4 2014, from $513122.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $513122.0 in Q1 2014 to a low of -$10.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2014 | -10.00 |
| Oct 31, 2014 | -10.00 |
| Jan 31, 2014 | 513,122.00 |
| Jan 31, 2014 | 513,122.00 |